Nasdaq:US$16.42 (-0.03) | HKEX:HK$26.10 (-0.45) | AIM:£2.71 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 20 Jan 2017

ASCO GI 2017: Fruquintinib in Combination with Paclitaxel in 2L Gastric Cancer

A Phase I/II Trial of Fruquintinib in Combination with Paclitaxel for Second-line Treatment in Patients with Advanced Gastric Cancer

Ruihua Xu, Dongsheng Zhang, Lin Shen, Jin Li, Jing Huang, Yang Zhang, Jifang Gong, Weijian Guo, Songhua Fan, Ke Li, Ye Hua and Weiguo Su

Event: ASCO GI

Title: A Phase I/II Trial of Fruquintinib in Combination with Paclitaxel for Second-line Treatment in Patients with Advanced Gastric Cancer

Abstract number: 128

Session: Poster Session A: Cancers of the Esophagus and Stomach

Date & Time: Thursday, January 19, 2017, 12:30 PM-6:30 PM (PST)